A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

NCT07631000 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal-junction Cancer

Interventions

DRUG: Cadonilimab

Sponsor

Memorial Sloan Kettering Cancer Center